Trade Paratek Pharma - PRTK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024318% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002096% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 2.17 |
| Open | 2.17 |
| 1-Year Change | -12.15% |
| Day's Range | 2.17 - 2.22 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 20, 2023 | 2.22 | 0.05 | 2.30% | 2.17 | 2.22 | 2.17 |
| Sep 19, 2023 | 2.17 | 0.00 | 0.00% | 2.17 | 2.17 | 2.16 |
| Sep 18, 2023 | 2.16 | -0.01 | -0.46% | 2.17 | 2.18 | 2.16 |
| Sep 15, 2023 | 2.17 | -0.01 | -0.46% | 2.18 | 2.18 | 2.16 |
| Sep 14, 2023 | 2.17 | -0.01 | -0.46% | 2.18 | 2.18 | 2.17 |
| Sep 13, 2023 | 2.18 | -0.01 | -0.46% | 2.19 | 2.19 | 2.18 |
| Sep 12, 2023 | 2.19 | 0.00 | 0.00% | 2.19 | 2.19 | 2.19 |
| Sep 11, 2023 | 2.18 | -0.01 | -0.46% | 2.19 | 2.20 | 2.18 |
| Sep 8, 2023 | 2.19 | 0.01 | 0.46% | 2.18 | 2.19 | 2.18 |
| Sep 7, 2023 | 2.19 | 0.01 | 0.46% | 2.18 | 2.19 | 2.18 |
| Sep 6, 2023 | 2.18 | 0.01 | 0.46% | 2.17 | 2.19 | 2.17 |
| Sep 5, 2023 | 2.18 | 0.01 | 0.46% | 2.17 | 2.19 | 2.17 |
| Sep 1, 2023 | 2.17 | -0.02 | -0.91% | 2.19 | 2.20 | 2.17 |
| Aug 31, 2023 | 2.19 | 0.02 | 0.92% | 2.17 | 2.19 | 2.17 |
| Aug 30, 2023 | 2.18 | 0.01 | 0.46% | 2.17 | 2.20 | 2.17 |
| Aug 29, 2023 | 2.18 | 0.01 | 0.46% | 2.17 | 2.18 | 2.17 |
| Aug 28, 2023 | 2.17 | 0.01 | 0.46% | 2.16 | 2.18 | 2.16 |
| Aug 25, 2023 | 2.18 | 0.01 | 0.46% | 2.17 | 2.19 | 2.17 |
| Aug 24, 2023 | 2.18 | 0.02 | 0.93% | 2.16 | 2.18 | 2.16 |
| Aug 23, 2023 | 2.16 | 0.00 | 0.00% | 2.16 | 2.16 | 2.16 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Paratek Pharma Company profile
About Paratek Pharmaceuticals Inc
Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of novel life-saving therapies for life-threatening diseases. The Company's product include NUZYRA (omadacycline) is an oral and intravenous antibiotic for the treatment of community-acquired bacterial pneumonia and acute skin and skin structure infections caused by susceptible pathogens. Its other product includes SEYSARA, which is a oral therapy for the treatment of moderate to severe acne vulgaris.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Paratek Pharmaceuticals Inc revenues increased from $46.9M to $130.2M. Net loss decreased 39% to $59.1M. Revenues reflect Product revenue, net increase from $38.8M to $106.1M, Collaboration and royalty revenue increase from $1.5M to $8.2M, Government contract grant revenue increase from $3.4M to $9.2M. Lower net loss reflects Interest Expense decrease of 14% to $17.4M (expense).
Equity composition
Common Stock $.001 Par, 3/11, 100M auth., 13,467,933 issd. Insiders control 9.22%. IPO: 5/06 .3M shs. @ $6.50 per share by Bear, Stearns & Co. Inc. 02/09, Name changed from Novacea, Inc. 02/09, 5-for-1 reverse stock split. 10/14,1-for-12 reverse stock split.
| Industry: | Pharmaceuticals (NEC) |
75 Park Plaza
4th Floor
BOSTON
MASSACHUSETTS 02116
US
News
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
09:32, 4 December 2024
Silver price forecast 2025 and beyond: Third party price target
Rising interest rates and a strong dollar pushed silver to a two-year last September, but what lies ahead?
16:00, 3 December 2024
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
16:41, 28 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com